Secondhand exposure to vaping can cause serious respiratory issues - study

Innovation
May.31.2022
Secondhand exposure to vaping can cause serious respiratory issues - study
Although marketed as a safer alternative to cigarettes, vaping can still cause severe respiratory health issues in those repeatedly exposed to it.

Using an e-cigarette may not actually be that much safer than smoking a traditional cigarette and can still cause significant respiratory problems, both for smokers and those around them, new research published by the University of Southern California has found.

 

The use of e-cigarettes, known as vaping, is often marketed as a healthier alternative to traditional cigarette smoking, as they don’t contain tar, one of the main components of a traditional cigarette responsible for damaging the lungs. However, they still contain nicotine, the component that makes smoking addictive, and many other chemicals, all of which combine to create an aerosol that the user then inhales.

 

As more research is done surrounding the use of e-cigarettes, medical professionals are piecing together a picture of the harm that they can do. A new peer-reviewed study from the Department of Population and Public Health Science at the University of Southern California, LA, examines the impact that the secondhand smoke from vaping can cause.

 

Can respiratory symptoms develop as a result of secondhand vape exposure?

 

The study, entitled “Secondhand nicotine vaping at home and respiratory symptoms in young adults,” works to examine whether or not exposure to secondhand nicotine vape smoke is associated with adverse respiratory health symptoms among young adults.

 

In order to assess their objective, the research team, led by Prof. Talat Islam, examined data spanning a six-year period between 2014-2019 regarding the prevalence of bronchitis and shortness of breath in high-school students aged 17-18 years. In total, 2090 students participated in the study.

 

Conducting the study

 

During the first phase of the study in 2014, the students completed questionnaires detailing their exposure to vape smoke and their medical history. Then, three additional follow-up questionnaires were completed over the subsequent years, in 2015, 2017, and 2018.

 

However, of the original 2090 students, 23% left the study after the completion of high school and did not participate in any of the follow-up assessments. Nevertheless, the researchers note that the prevalence of secondhand nicotine vape exposure, bronchitic symptoms and shortness of breath did not differ substantially between those who left the study early and those who remained.

 

The respiratory symptoms measured were bronchitic symptoms such as wheezing and shortness of breath experienced in the last 12 months. If participants responded that they had experienced either bronchitis in the last year, a daily cough for three consecutive months, or congestion even when not accompanied by a cold, they were considered to have bronchitic symptoms.

 

Wheeze symptoms were based on a report of wheezing or whistling in the chest during the previous year, and shortness of breath was based on a report of having trouble breathing when hurrying on level ground or walking up a slight hill.

 

At each stage of the study, detailed information regarding secondhand exposure to e-cigarette aerosol, as well as cigarette smoke, was collected from the participants. Secondhand nicotine vape exposure was defined based on participants’ reports that anyone in their household, other than themselves, used e-cigarettes or other similar devices. Secondhand smoking exposure was defined based on reports of secondhand exposure to combustible tobacco.

 

Upon the completion of the data collection stages of the study, the research teamed turned to the statistical analysis portion of the research. They evaluated the association between secondhand nicotine vape exposure and respiratory symptoms at each stage of the study, adjusting as necessary to account for whether or not the participant themself smoked, ensuring that this would not skew the results of the study.

 

The results of the study

 

Following the analysis of the data, the research team discovered that the prevalence of secondhand nicotine vape exposure increased from 11.7% in 2014 to 15.6% in 2018, while the prevalence of secondhand smoking decreased from 26.6% to 20.6% in the same time period.

 

Over the study period, an increase in the prevalence of wheeze and bronchitic symptoms was observed in the study participants. Wheeze symptoms increased from 12.3% to 14.9%, while bronchitic symptoms increased from 19.4% to 26.0%. The prevalence of shortness of breath did not show any clear trend over time.

 

The data also showed a clear increase in respiratory symptoms in people who were exposed to secondhand nicotine vaping compared to people who were not. Compared with unexposed participants, participants with secondhand vape exposure were found to be 40% more likely to develop bronchitis symptoms and 53% to have shortness of breath symptoms, compared with participants who were not passively exposed to e-cigarettes.

 

Commenting on the study’s findings, the researchers state that to their knowledge, this is the first extended study-based report of the effects of secondhand nicotine vape exposure on respiratory symptoms among adolescents and young adults.

 

Source:THE JERUSALEM POST

China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
Australian authorities have disclosed two major enforcement actions that go beyond product seizures and retail closures to examine how illicit tobacco and vape networks operate. On Aug. 14, the Multi Agency Strike Team said seven people had been charged and two criminal networks were valued by authorities at a combined A$80 million, or about US$56.8 million. Investigators allege the groups used bonded warehouses, freight businesses and “trusted insiders” in legitimate industries to circumvent border controls. In a separate operation on Aug. 11, more than 100 service stations were targeted as authorities sought information on illicit tobacco importation, distribution networks and the movement of sales proceeds.
Aug.17
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24